Holdings of PROFUND VP HEALTH CARE
ProFunds ·59 declared positions · as of Mar 31, 2026
Original filing · Net assets 29.8M $ · Ten largest lines: 59.2 % of the equity sleeve
Sector breakdown
- Health care 95.6 %
- Materials 0.6 %
- Consumer discretionary 0.3 %
- Unattributed 3.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 59 | 28.7M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 4,292 | 3.9M $ | 13.23 % |
| 2 | Johnson & Johnson | 13,054 | 3.2M $ | 10.70 % |
| 3 | AbbVie Inc | 9,573 | 2.1M $ | 6.98 % |
| 4 | Merck & Co Inc | 13,444 | 1.6M $ | 5.42 % |
| 5 | UnitedHealth Group Inc | 4,907 | 1.3M $ | 4.45 % |
| 6 | Amgen Inc | 2,917 | 1M $ | 3.44 % |
| 7 | Thermo Fisher Scientific Inc | 2,035 | 1M $ | 3.35 % |
| 8 | Abbott Laboratories | 9,419 | 967K $ | 3.24 % |
| 9 | Gilead Sciences Inc | 6,720 | 936.6K $ | 3.14 % |
| 10 | Intuitive Surgical Inc | 1,924 | 886.9K $ | 2.97 % |
| 11 | Pfizer Inc | 30,798 | 864.8K $ | 2.90 % |
| 12 | Bristol-Myers Squibb Co | 11,031 | 669K $ | 2.24 % |
| 13 | Danaher Corp | 3,408 | 646.2K $ | 2.17 % |
| 14 | Vertex Pharmaceuticals Inc | 1,376 | 614.4K $ | 2.06 % |
| 15 | Stryker Corp | 1,866 | 613.1K $ | 2.06 % |
| 16 | Medtronic PLC | 6,944 | 601.7K $ | 2.02 % |
| 17 | McKesson Corp | 663 | 573.7K $ | 1.92 % |
| 18 | Boston Scientific Corp | 8,033 | 504.1K $ | 1.69 % |
| 19 | CVS Health Corp | 6,891 | 494.9K $ | 1.66 % |
| 20 | Regeneron Pharmaceuticals, Inc. | 546 | 421.9K $ | 1.41 % |
| 21 | HCA Healthcare Inc | 848 | 401.3K $ | 1.35 % |
| 22 | Cigna Group/The | 1,427 | 380.7K $ | 1.28 % |
| 23 | Elevance Health Inc | 1,195 | 349.8K $ | 1.17 % |
| 24 | Cencora Inc | 1,054 | 331.1K $ | 1.11 % |
| 25 | Zoetis Inc | 2,287 | 270.3K $ | 0.91 % |
| 26 | Cardinal Health, Inc. | 1,275 | 269.4K $ | 0.90 % |
| 27 | Edwards Lifesciences Corp | 3,143 | 251.7K $ | 0.84 % |
| 28 | IDEXX Laboratories Inc | 433 | 243.3K $ | 0.82 % |
| 29 | Becton Dickinson & Co | 1,542 | 242.4K $ | 0.81 % |
| 30 | ResMed Inc | 789 | 177.1K $ | 0.59 % |
| 31 | GE HealthCare Technologies Inc | 2,469 | 175.7K $ | 0.59 % |
| 32 | Agilent Technologies Inc | 1,532 | 174.6K $ | 0.59 % |
| 33 | Waters Corp | 531 | 158.1K $ | 0.53 % |
| 34 | IQVIA Holdings Inc | 919 | 156.7K $ | 0.53 % |
| 35 | Biogen Inc | 795 | 145.7K $ | 0.49 % |
| 36 | Mettler-Toledo International Inc | 110 | 138.7K $ | 0.47 % |
| 37 | Dexcom Inc | 2,085 | 130.9K $ | 0.44 % |
| 38 | Labcorp Holdings Inc | 449 | 119.8K $ | 0.40 % |
| 39 | STERIS PLC | 531 | 117.4K $ | 0.39 % |
| 40 | Quest Diagnostics Inc | 596 | 116.8K $ | 0.39 % |
| 41 | Humana Inc | 653 | 113.2K $ | 0.38 % |
| 42 | West Pharmaceutical Services Inc | 390 | 97.7K $ | 0.33 % |
| 43 | Zimmer Biomet Holdings Inc | 1,073 | 97K $ | 0.33 % |
| 44 | Moderna Inc | 1,884 | 95.7K $ | 0.32 % |
| 45 | Hologic Inc | 1,206 | 91.2K $ | 0.31 % |
| 46 | Incyte Corp | 906 | 85.3K $ | 0.29 % |
| 47 | Viatris Inc | 6,239 | 84.3K $ | 0.28 % |
| 48 | Centene Corp | 2,531 | 82.9K $ | 0.28 % |
| 49 | Insulet Corp | 381 | 79.9K $ | 0.27 % |
| 50 | Cooper Cos Inc/The | 1,062 | 75.9K $ | 0.25 % |
| 51 | Align Technology Inc | 361 | 61.9K $ | 0.21 % |
| 52 | Revvity Inc | 614 | 53.8K $ | 0.18 % |
| 53 | Universal Health Services Inc | 299 | 53.5K $ | 0.18 % |
| 54 | Solventum Corp | 799 | 52.2K $ | 0.17 % |
| 55 | Baxter International Inc | 2,787 | 46.8K $ | 0.16 % |
| 56 | Charles River Laboratories International Inc | 267 | 46.1K $ | 0.15 % |
| 57 | Bio-Techne Corp | 847 | 44.3K $ | 0.15 % |
| 58 | Henry Schein Inc | 542 | 39.9K $ | 0.13 % |
| 59 | DaVita Inc | 181 | 27.8K $ | 0.09 % |